Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04558307 · ClinicalTrials.gov registry record
Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04558307: Completed study, sponsored by Mayo Clinic.
NCT04558307 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04558307 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility of establishing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing at a federally-qualified health center (FQHC) during a global health crisis to mitigate COVID-19 disparities in socioeconomically disadvantaged populations.
Interventions
- DIAGNOSTIC_TEST Pilot a rapid SARS-CoV-2 testing strategy
- OTHER Community-driven messages to promote COVID-19 testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-06-03 |
| Est. Completion | 2021-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04558307
The ClinicalTrials.gov registry entry for NCT04558307 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pilot a rapid SARS-CoV-2 testing strategy is the first listed.
NCT04558307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04558307 about?
NCT04558307 is a clinical study titled "Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations". The purpose of this study is to assess the feasibility of establishing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing at a federally-qualified health center (FQHC) during a global health crisis to mitigate COVID-19 disparities in socioeconomically disadvantaged populations.
What is the current status of trial NCT04558307?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2020-06-03. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT04558307?
The interventions under investigation include: Pilot a rapid SARS-CoV-2 testing strategy (DIAGNOSTIC_TEST), Community-driven messages to promote COVID-19 testing (OTHER).
Who is sponsoring clinical trial NCT04558307?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.